Synthesis and biological evaluation of cajanonic acid A derivatives as potential PPARγ antagonists
作者:Jian-Ta Wang、Jin-Gang Peng、Jing Xia、Ji-Quan Zhang、Chu-Jiao Hu、Gao-Feng Zhu、Bing Guo、Lei Tang
DOI:10.1016/j.bmcl.2021.128410
日期:2021.11
designed and synthesized. The newly prepared compounds have been screened for glucose consumption activity in HepG2 cell lines and PPARγ antagonistic activity in HEK293 cell lines. Compound 26g bearing a tetrahydroisoquinolinone scaffold showed the most potent PPARγ antagonistic and hypoglycemic activities. An oral glucose tolerance test (OGTT) was performed and the results further confirmed that 26g was a
已经设计和合成了四个系列的cajanonic acid A (CAA) 衍生物。已经筛选了新制备的化合物在 HepG2 细胞系中的葡萄糖消耗活性和在 HEK293 细胞系中的 PPARγ 拮抗活性。带有四氢异喹啉酮支架的化合物26g显示出最有效的 PPARγ 拮抗和降血糖活性。进行了口服葡萄糖耐量试验(OGTT),结果进一步证实26g是一种有效的降糖药。此外,本研究还研究了 PPARγ 蛋白中化合物26g的可能结合模式。